Literature DB >> 32401285

Big Data Begin in Psychiatry.

Myrna M Weissman1,2,3.   

Abstract

The last 40 years of JAMA Psychiatry are reviewed as a celebration of its achievements. The focus of this article is on the evolution of big data as reflected in key journal articles. The review begins in 1984 with the introduction of the Epidemiology Catchment Area (ECA) study and Freedman's editorial "Psychiatric Epidemiology Counts." The ECA study (N = 17 000), for the first time in a survey, used clinical diagnosis in 5 urban communities, thus linking research and care to population rates of psychiatric diagnosis. The review then traces the subsequent evolution of big data to 5 overlapping phases, other population surveys in the US and globally, cohort studies, administrative claims, large genetic data sets, and electronic health records. Each of these topics are illustrated in articles in JAMA Psychiatry. The many caveats to these choices, the historical roots before 1984, as well as the controversy around the choice of topics and the term big data are acknowledged. The foundation for big data in psychiatry was built on the development of defined and reliable diagnosis, assessment tools that could be used in large samples, the computational evolution for handling large data sets, hypothesis generated by smaller studies of humans and animals with carefully crafted phenotypes, the welcoming of investigators from all over the world with calls for broader diversity, open access and the sharing of data, and introduction of electronic health records more recently. Future directions as well as the opportunities for the complementary roles of big and little data are described. JAMA Psychiatry will continue to be a rich resource of these publications.

Entities:  

Mesh:

Year:  2020        PMID: 32401285     DOI: 10.1001/jamapsychiatry.2020.0954

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  7 in total

1.  Early Diagnosis of Bipolar Disorder Coming Soon: Application of an Oxidative Stress Injury Biomarker (BIOS) Model.

Authors:  Zhiang Niu; Xiaohui Wu; Yuncheng Zhu; Lu Yang; Yifan Shi; Yun Wang; Hong Qiu; Wenjie Gu; Yina Wu; Xiangyun Long; Zheng Lu; Shaohua Hu; Zhijian Yao; Haichen Yang; Tiebang Liu; Yong Xia; Zhiyu Chen; Jun Chen; Yiru Fang
Journal:  Neurosci Bull       Date:  2022-05-19       Impact factor: 5.271

2.  Using Danish national registry data to understand psychopathology following potentially traumatic experiences.

Authors:  Jaimie L Gradus; Anthony J Rosellini; Péter Szentkúti; Erzsébet Horváth-Puhó; Meghan L Smith; Isaac Galatzer-Levy; Timothy L Lash; Sandro Galea; Paula P Schnurr; Henrik T Sørensen
Journal:  J Trauma Stress       Date:  2022-01-27

3.  Challenges of Building, Deploying, and Using AI-Enabled Telepsychiatry Platforms for Clinical Practice Among Urban Indians: A Qualitative Study.

Authors:  Arunkumar Annamalai
Journal:  Indian J Psychol Med       Date:  2020-12-19

4.  Big data and predictive analytics in healthcare in Bangladesh: regulatory challenges.

Authors:  Shafiqul Hassan; Mohsin Dhali; Fazluz Zaman; Muhammad Tanveer
Journal:  Heliyon       Date:  2021-05-29

5.  Enduring problems in the offspring of depressed parents followed up to 38 years.

Authors:  Myrna M Weissman; Ardesheer Talati; Marc J Gameroff; Lifang Pan; Jamie Skipper; Jonathan E Posner; Priya J Wickramaratne
Journal:  EClinicalMedicine       Date:  2021-07-13

Review 6.  The epidemiology of psychiatric disorders in Africa: a scoping review.

Authors:  M Claire Greene; Tenzin Yangchen; Thomas Lehner; Patrick F Sullivan; Carlos N Pato; Andrew McIntosh; James Walters; Lidia C Gouveia; Chisomo L Msefula; Wilza Fumo; Taiwo L Sheikh; Melissa A Stockton; Milton L Wainberg; Myrna M Weissman
Journal:  Lancet Psychiatry       Date:  2021-06-08       Impact factor: 77.056

7.  A qualitative study of big data and the opioid epidemic: recommendations for data governance.

Authors:  Elizabeth A Evans; Elizabeth Delorme; Karl Cyr; Daniel M Goldstein
Journal:  BMC Med Ethics       Date:  2020-10-21       Impact factor: 2.652

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.